<DOC>
	<DOC>NCT02065817</DOC>
	<brief_summary>This is a pilot study to determine the optimum time and dose to draw blood samples using a tracer for HDL kinetics.</brief_summary>
	<brief_title>Dose of Labeled Cholesterol for Kinetics: A Pilot Study</brief_title>
	<detailed_description />
	<criteria>â€¢ Healthy men and women ages 18 50 Cardiovascular disease Metabolic disease Hematologic disorder Liver or kidney disease phenylketonuria Currently taking lipid lowering medications or any other drugs that could affect lipid metabolism</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Lipid</keyword>
	<keyword>Apolipoproteins</keyword>
	<keyword>Cardiovascular disease risks</keyword>
</DOC>